Quoin Pharmaceuticals Is Maintained at Buy by Maxim Group

Quoin Pharmaceuticals Is Maintained at Buy by Maxim Group

Dow JonesMar 15 23:25

Maxim Group Maintains Buy on Quoin Pharmaceuticals, Lowers Price Target to $4

Maxim Group analyst Naz Rahman maintains Quoin Pharmaceuticals with a Buy and lowers the price target from $15 to $4.

Analyst UpgradesMar 15 23:15

Quoin Pharmaceuticals Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/15/2024 327.76% Maxim Group $15 → $4 Maintains Buy 09/07/2022 2038.81% Alliance Global Partners → $20 I

BenzingaMar 15 23:13

Earnings Call: Quoin Pharmaceuticals Reports Q4 Progress and Outlook

InvestingMar 15 09:26

Earnings Call Summary | Quoin Pharmaceuticals(QNRX.US) Q4 2023 Earnings Conference

The following is a summary of the Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Call Transcript:Financial Performance:Quoin Pharmaceuticals Ltd ended the year with around $10.7 million cash and

Futu NewsMar 15 01:45 · Conference Call

Quoin Pharmaceuticals: Q4 Earnings Insights

Quoin Pharmaceuticals (NASDAQ:QNRX) reported its Q4 earnings results on Wednesday, March 13, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsQuoin Pharmaceuticals be

BenzingaMar 14 04:15